Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 55Carcinoma, Hepatocellular 40Neoplasms 38Polycystic Ovary Syndrome 27Colorectal Neoplasms 24Stomach Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Prostatic Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Recurrence 13Pancreatic Neoplasms 13Lymphoma 13Liver Neoplasms 13Urinary Bladder Neoplasms 11Leukemia, Myeloid, Acute 11Esophageal Neoplasms 11Leiomyoma 10Colonic Neoplasms 10Pain 9Lung Neoplasms 9Multiple Myeloma 8Uterine Cervical Neoplasms 7Neoplasm Metastasis 7Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Keratosis, Actinic 7Infertility 7Papillomavirus Infections 6Pain, Postoperative 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

Saline Solution, Hypertonic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Osmotherapy × Clear all
NCT01745081 2012-12-07

Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial Craniotomies

Université de Sherbrooke

Phase 4 Unknown
80 enrolled

Osmotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡